iBio, Inc.

IBIO Healthcare Biotechnology

In the quarter to June 2026, revenue grew 100.0%, EPS grew 77.4% and free cash flow fell 35.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.77 0.01 −1.28%
Market cap
$47.6M
P/E
0.0×
Fwd P/E
−7.7×
Dividend yield
—
F-score
4/9
Altman Z
2.80
Beneish M
33.49
Dividend safety
n/a
Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Jun '24 Jun '25 Jun '26
Piotroski F-Score
2 3 2 3 3 3 — — — 4
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
Altman Z-Score
(3.11) (3.34) (6.14) 0.24 3.08 (3.00) — (16.05) (21.93) 2.80
P/S ratio
88.10 20.87 6.57 85.11 124.60 27.63 — 3.80 12.77 269.79
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(7.65) (6.09) (14.37) (0.69) 2.07 (6.53) — (33.77) (49.20) (2.35)
P/Operating CF
(9.22) (2.75) (3.02) (36.05) (40.88) (4.93) — (1.59) (1.73) (29.24)
Beneish M-Score
(4.15) (3.26) (0.48) 64.75 (1.87) (1.94) — — (3.22) 33.49
P/B ratio
3.89 0.57 5.40 2.46 2.72 0.89 — 0.36 0.54 2.12
EV/Sales
131.23 41.03 16.61 71.56 97.50 24.77 — (2.94) 1.39 141.38
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 — 0.39 0.00 0.00
EV/FCF
(3.50) (1.25) (2.24) (8.00) (6.56) (1.03) — 0.31 (0.05) (3.94)
Current Ratio
4.26 8.00 1.39 11.79 15.74 1.48 1.19 4.08 1.59 7.85
Net Debt/EBITDA
(1.36) (0.73) (1.46) 1.89 2.26 0.31 (0.23) 0.89 0.44 2.57
Debt/Equity
2.83 1.55 10.13 0.58 0.30 0.40 0.89 0.06 0.06 0.00
ROE
(88.73%) (130.51%) (191.75%) (129.55%) (28.41%) (58.58%) (164.86%) (135.71%) (101.52%) (65.70%)
ROA
(33.38%) (41.38%) (48.47%) (61.33%) (19.46%) (40.91%) (92.47%) (71.22%) (70.79%) (54.04%)
ROIC
(34.19%) (35.13%) (43.05%) (25.44%) (43.88%) (33.36%) (84.34%) (135.39%) (163.11%) 0.00%
Return on Tangible Assets
(45.48%) (41.53%) (69.39%) (63.59%) (22.02%) (314.81%) (776.80%) (161.06%) (271.13%) (39.54%)
Average Days of Receivables
162.12 61.66 17.54 1,253.21 850.69 1,181.79 0.00 1,156.64 95.81 4,029.60
Earnings Yield
(41.03%) (166.85%) (133.46%) (38.64%) (8.61%) (87.75%) — (323.22%) (228.95%) (19.43%)
Free Cash Flow Yield
(42.51%) (157.13%) (112.82%) (10.50%) (11.92%) (86.62%) — (247.80%) (199.23%) (13.30%)
Free Cash Flow per Share
(828.99) (683.52) (394.85) (115.44) (90.02) (112.61) (54.86) (4.61) (1.46) (0.23)
Book value per Share
500.84 758.87 64.83 450.69 277.45 145.57 25.13 5.57 1.42 0.82
Free Cash Flow
(14.76) (14.56) (14.96) (14.50) (35.23) (49.11) (33.57) (17.65) (15.32) (23.80)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 — 0.36 0.00 0.00
Other line items

Show all line items

Columns are period end dates